OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis

Abaloparatide (ABL) is a novel, selective activator of the PTH1 receptor signaling pathway. In the 18-month Phase 3 ACTIVE study in women with postmenopausal osteoporosis (OP) (NCT01343004), ABL significantly increased bone mineral density (BMD), and decreased the risk of new vertebral (VF), nonvert...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Endocr Soc
Main Authors: Lane, Nancy, Mitlak, Bruce, Weiss, Richard, Wang, Yamei, Valenzuela, Guillermo, Bilezikian, John
格式: Artigo
語言:Inglês
出版: Endocrine Society 2019
主題:
Bone and Mineral Metabolism
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554836/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-OR03-1
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍